INO

SEC filing INO Amends Bylaws, Elects 8 Directors, Approves Ernst & Young, Passes NEO Compensation and Omnibus Incentive Plan with 58.57% Quorum

12d ago

News Inovio outlines cash runway into Q1 2027 as INO-3107 targets October 30, 2026 PDUFA date

19d ago

News Earnings Snapshot: Inovio Pharmaceuticals' Q1 shows EPS beat; net loss $19.7M improves as R&D costs fall

19d ago

Short volume Short volume 69% of volume (3.4σ)

30d ago

News Inovio targets October 30 PDUFA date for INO-3107 approval while extending cash runway into Q4 2026

81d ago

News Is Inovio Pharmaceuticals Stock Going to $0?

99d ago

News *CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO

138d ago

News Jefferies reiterates Hold on Inovio stock amid FDA review uncertainty

153d ago

Scanner Unusual volume (z=5.1)

165d ago

Scanner Unusual volume (z=3.2)

168d ago